“As health plans look to set up the right structure that aligns incentives in support of value based reimbursement, the IPG program truly sets the stage to drive quality and affordability from optimal device selection and utilization, and site of care to truly impact surgical costs. DJO Surgical’s products contribute to lowering surgical costs and patient out of pocket costs. A true win-win,” said Mark Russell, senior vice president of sales, marketing, and commercial logistics for DJO Surgical.
The IPG platform enables surgeons, facilities and device manufacturers to play an active role in the delivery of cost effective surgical care. DJO’s focus on value-driven implant systems and state-of-the-art technology strongly aligns with IPG’s mission of ensuring and enabling the delivery of high quality, cost effective surgical care.
“We are thrilled to work with high quality manufacturers like DJO, who focus on lowering total episodic care through surgical efficiency for patients and health plans,” said Vince Coppola, president and CEO of IPG. “These partnerships continue to expand our ability to deliver on our cost and quality objectives for our health plan clients. Since our programs align incentives and goals between surgeons, facilities, health plans and manufacturers, DJO is now part of the team with the important mission of making health care more affordable.”
DJO’s surgical portfolio includes a full suite of advanced solutions for hip, knee, and shoulder arthroplasty with an emphasis on incorporating modern technology while capturing both surgical and cost efficiencies that will be accessible to IPG’s expansive network of direct partnering facilities and surgeons.